The purpose of this study was to examine the effects of ghrelin on protein kinase B (Akt) and mitogen-activated protein kinase p42/44 (ERK1/2) activation as well as ghrelin effects on inducible nitric oxide (NO) synthase (iNOS; for gene Nos2) activity/expression in rat hearts. Male Wistar rats were treated with ghrelin (0.3 nmol/5 μl) or an equal volume of phosphate-buffered saline, injected every 24 h into the lateral cerebral ventricle for 5 days and 2 h after the last treatment the animals were sacrificed. Serum NO, L-arginine (L-Arg), and arginase activity were measured spectrophotometrically. For phosphorylation of Akt, ERK1/2, and iNOS protein expression, Western blot method was used. The expression of Nos2 mRNA was measured by the quantitative real-time polymerase chain reaction (qRT-PCR). Treatment with ghrelin significantly increased NO production in serum by 1.4-fold compared with control. The concentration of L-Arg was significantly higher in ghrelin-treated rats than in control while arginase activity was significantly lower in ghrelin-treated than in control hearts. Ghrelin treatment increased phosphorylation of Akt by 1.9-fold and ERK1/2 by 1.6-fold and increased iNOS expression by 2.5-fold compared with control. In addition, ghrelin treatment increased Nos2 gene expression by 2.2-fold as determined by qRT-PCR. These results indicate that ghrelin regulation of iNOS expression/activity is mediated via Akt/ERK1/2 signaling pathway. These results may be relevant to understanding molecular mechanisms underlying direct cardiovascular actions of ghrelin.

No abstract

X-chromosome instability has been a long established feature in Alzheimer's disease (AD). Premature centromere division and aneuploidy of the X-chromosome has been found in peripheral blood lymphocytes and neuronal tissue in female AD patients. Interestingly, only one chromosome of the X pair has been affected. These results raised a question, "Is the X-chromosome inactivation pattern altered in peripheral blood lymphocytes of women affected by AD?" To address this question, we analyzed the methylation status of androgen receptor promoter which may show us any deviation from the 50 : 50% X inactivation status in peripheral blood lymphocytes of women with AD. Our results showed skewed inactivation patterns (>90%). These findings suggest that an epigenetic alteration on the inactivation centers of the X-chromosome (or skewing) relates not only to aging, by might be a novel property that could account for the higher incidence of AD in women.

Estrogen regulates many different and sometimes quite opposite processes in cells. Since the discovery of estrogen receptor (ER), the last few decades have resulted in a better understanding of estrogen biology. Estrogen is involved in processes leading to different pathologies in estrogen responsive tissues, not only carcinogenesis, but this was one of the most investigated fields in estrogen-related pathology. The exact role of estrogen in these pathologies is not completely understood due to the complex interplay of its receptors with other signaling pathways. This review considers the latest literature focused on estrogen and ERs as potential therapeutic targets in the treatment of malignant disease (e.g. breast, prostate, ovarian and endometrial cancer)

The goal of this study was to identify host and viral factors affecting the response to pegylated interferon/ribavirin (PEG-IFN/RBV) treatment in patients with chronic hepatitis C genotype 1b. Baseline characteristics of the patients and sequences within the p7 region were analyzed in pre-treatment serum samples from 53 individuals with chronic hepatitis C genotype 1b and related to the outcome of therapy. We found a significant correlation between age and response to therapy (p < 0.001). Furthermore, the pre-treatment viral load was closely associated with the stage of liver fibrosis (p < 0.001). The presence of fewer than 4 mutations and age above 40 were significantly associated with non-response (NR) (p < 0.001). Our findings may be useful for estimating the likelihood of achieving a sustained virologic response (SVR) in patients who are chronically infected with hepatitis C virus genotype 1b.

No abstract

No abstract

Carbonaceous materials as well as its form functionalized with metallic silver have been prepared by hydrothermal carbonization of fructose. Results are presented to show that nanostructured silver was obtained through the functionalization process. The carbonaceous materials were characterized by: nitrogen adsorption/desorption measurement, XRD, SEM/EDS and FTIR. Samples functionalized with silver were analyzed by: XRD and SEM/EDS. The XRD analysis showed that the carbonaceous materials functionalized with silver by hydrothermal carbonization process were successfully performed. Size of silver particles was found to be approximately 32 nm, indicating formation of nanostructure. All samples were tested as an antimicrobial agent for water disinfection. Presence of nanostructured silver in the sample containing 1 mg/mL carbonaceous materials significantly decreased the number of CFU (dCFU = 97.33 %) if compared to the same sample containing the same amount of carbonaceous materials but without of silver (dCFU 65.33 %).